PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 4,175.00
+215.00 (5.43%)
Apr 29, 2026, 3:30 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 91.49 billion as of April 29, 2026. Its market cap has increased by 29.18% in one year.
Market Cap
91.49B
Enterprise Value
96.83B
Revenue
171.66B
Ranking
n/a
PE Ratio
776.94
Stock Price
4,175.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 91.49B, an increase of 739.93%. That is a compound annual growth rate of 7.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 91.49B | 0.48% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 69.85T |
| Celltrion | 42.76T |
| ALTEOGEN | 20.28T |
| Samsung Epis Holdings | 14.08T |
| Kukje Pharma | 97.74B |
| Cellid, | 92.49B |
| Humasis | 90.64B |
| GeneOne Life Science | 88.23B |